Velactis

RSS

cabergoline

Suspended
This medicine is currently suspended from use in the European Union.

Overview

The marketing authorisation for Velactis has been suspended on the recommendation of the Agency's Committee for Medicinal Products for Veterinary Use (CVMP).

This EPAR was last updated on 04/10/2016

Authorisation details

Product details
Name
Velactis
Agency product number
EMEA/V/C/003739
Active substance
cabergoline
International non-proprietary name (INN) or common name
cabergoline
Anatomical therapeutic chemical veterinary (ATCvet) codes
QG02CB03
Publication details
Marketing-authorisation holder
Ceva Santé Animale
Revision
1
Date of issue of marketing authorisation valid throughout the European Union
09/12/2015
Contact address
10 Avenue de la Ballastiere
33500 Libourne
France

Product information

22/08/2016 Velactis - EMEA/V/C/003739 -

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • GENITO URINARY SYSTEM AND SEX HORMONES
  • other gynaecologicals
  • Prolactine inhibitors

Therapeutic indication

For use in the herd management programme of dairy cows as an aid in the abrupt drying-off by reducing milk production to:

  • reduce milk leakage at drying off;
  • reduce the risk of new intramammary infections during the dry period;
  • reduce discomfort.

Assessment history

How useful was this page?

Add your rating